Mercuriadis to become chair of Hipgnosis Songs Management
UK's Hipgnosis Songs Management said on Friday that founder Merck Mercuriadis will handover the CEO's position to Chief Operating Officer Ben Katovsky, and take on the role of chairman. ...
Stay updated with breaking news from Eva Mathews. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UK's Hipgnosis Songs Management said on Friday that founder Merck Mercuriadis will handover the CEO's position to Chief Operating Officer Ben Katovsky, and take on the role of chairman. ...
Music industry veteran Merck Mercuriadis has stepped down as the CEO of Hipgnosis Songs Management , the artist management firm he founded, in a move that could help improve relations with the...
Embattled British fashion retailer Superdry said on Friday top shareholder and CEO Julian Dunkerton was looking at options for the company, which may include a cash offer for the shares not already...
GSK said on Thursday it agreed to confidentially settle one more lawsuit in California that alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of settlements to end...
In 2019, some manufacturers and pharmacies halted Zantac sales over concerns that its active ingredient, ranitidine, degraded over time to form a chemical called NDMA. While NDMA can be present in low levels in food and water, research has found it causes cancer in larger amounts. The U.S. Food and Drug Administration (FDA) in 2020 pulled Zantac and its generic versions off the market, triggering a wave of lawsuits.